Litcius/Paper detail

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial

Mark F. Cotton, Shabir A. Madhi, Angelique Kany Kany Luabeya, Michèle Tameris, Anneke C. Hesseling, Justin Shenje, Elisma Schoeman, Mark Hatherill, Sajjad Desai, Dhananjay Kapse, Sina Brückner, Anthonet Koen, Lisa Jose, Andrew Moultrie, Sutika Bhikha, Gerhard Walzl, Andrea Gutschmidt, Leigh A. Kotzé, Devon Allies, André G. Loxton, Umesh Shaligram, M. Roselle Abraham, Hilary Johnstone, Leander Grode, Stefan H. E. Kaufmann, Prasad S. Kulkarni

2022The Lancet Infectious Diseases69 citationsDOI

Topics & Concepts

MedicineTuberculosisPediatricsVaccinationIncidence (geometry)Adverse effectBreastfeedingInternal medicineImmunologyPathologyOpticsPhysicsImmune responses and vaccinationsTuberculosis Research and EpidemiologyImmunodeficiency and Autoimmune Disorders